| June 4, 2015 | ISSUE NUMBER 403 VOL 4 |
Top Story
Repairing Pharma's Reputation: 5 Patient Strategies
Pharma's image is still suffering despite a rise in medical innovation. Dan Bobear offers five patient-centered strategies that could help in finally mending the gap
...Read more
You started with a sales force, added direct-to-consumer advertising, and a whole host of other marketing channels followed. And you invest in the technology to support them all. Are you getting the ROI you need?
 Watch this video
to learn about the three technologies essential for customer-centric marketing.
Event
ASCO: Combos and Pricing and Pricing of Combos
Casey McDonald presents some highlights from a blustery few days at the American Society of Clinical Oncology event in Chicago, where immunotherapy and cost predictably took center stage
...Read more
Regulatory
More Mandates for FDA
New proposals from Congress to spur innovation will strain resources needed for regulatory approval, writes Jill Wechsler
...Read more
Worldwide Clinical Trials
Scientifically Minded, Medically Driven
You work tirelessly to bring better products to market and improve patients' lives. At WCT, we support you by consistently delivering quality results, on-time, on-budget and always bolstered
by unrivaled science and medicine. Flexible. Reliable. Committed.
 We aren't satisfied until you are.
Join us at DIA, Booth #1311!
Emerging Markets
Big Data's Big Opportunity in China
Bryan Spielman outlines why China is poised for a data renaissance—one that could play a pivotal role in the next wave of pharma innovation
...Read more
R&D
Speeding Up Clinical Trials — What Works and What Doesn't
While increasing the speed and efficiency of clinical trials is an agreed-upon priority, what is less well understood is which approaches have worked which haven't in recent years. Michael Christel reports.
...Read more
|
|
|
 //NeoStem (New York, NY) announced plans to change its corporate name to Caladrius Biosciences, Inc., effective June 8, 2015. //Juno Therapeutics (Seattle, WA) appointed Hyam I. Levitsky, M.D., as Executive
Vice President, Research and Chief Scientific Officer.
//Catalyst Pharmaceuticals (Coral Gables, FL) appointed Richard J. Daly to the position of interim Chief Commercial Officer. //inVentiv Health (Burlington, MA) announced the appointment of Michael McKelvey, Ph.D., as President, inVentiv Health Clinical Division and Executive Vice President, inVentiv Health. //Amyris (Emeryville, CA) announced the planned resignation of Dr. Nam-Hai Chua and the designation of Bram Klaeijsen to serve as a member of Amyris's Board of Directors. //AMAG Pharmaceuticals (Waltham, MA) named Julie Krop, M.D., as Chief Medical officer and Senior Vice President, Clinical Development and Regulatory Affairs, and Audrey Wu as Vice President of Commercial Strategy and Marketing for the company's maternal health business. // |
|
|
|
|
|
